Renovo is a privately held pharmacetutical company specializing in the commercialization of pharmaceutical cocrystals. Renovo identifies new, patentable, solid forms of active pharmaceutical ingredients (APIs) that can significantly improve the physical properties of the API. The primary focus of this effort is improving the bioavailability of poorly soluble APIs by incorporating high solubility cocrystals into a proprietary supersaturating drug delivery system.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://renovoresearch.com
Renovo Research Questions
Renovo Research's website is http://renovoresearch.com
Renovo Research's LinkedIn profile is https://www.linkedin.com/company/renovo-research
Renovo Research has
1 employees.
View email and phone details for 1
employees at Renovo Research.
Renovo Research's industry is
Pharmaceutical Manufacturing
Renovo Research's top competitors are
Lifemine Therapeutics,
Solid State Pharma,
Lincoln Pharmaceuticals Ltd,
Lyndra Therapeutics.
Renovo Research's categories are Pharmaceutical Manufacturing
Renovo Research's founding year is 2008
